These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29277141)

  • 21. Computational study of the heterodimerization between mu and delta receptors.
    Liu X; Kai M; Jin L; Wang R
    J Comput Aided Mol Des; 2009 Jun; 23(6):321-32. PubMed ID: 19214754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use multiscale simulation to explore the effects of the homodimerizations between different conformation states on the activation and allosteric pathway for the μ-opioid receptor.
    Zhang X; Yuan Y; Wang L; Guo Y; Li M; Li C; Pu X
    Phys Chem Chem Phys; 2018 May; 20(19):13485-13496. PubMed ID: 29726867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlated Motions of Conserved Polar Motifs Lay out a Plausible Mechanism of G Protein-Coupled Receptor Activation.
    Mitra A; Sarkar A; Szabó MR; Borics A
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity.
    Borics A; Tóth G
    J Mol Graph Model; 2010 Feb; 28(6):495-505. PubMed ID: 20036591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into µ-opioid receptor activation.
    Huang W; Manglik A; Venkatakrishnan AJ; Laeremans T; Feinberg EN; Sanborn AL; Kato HE; Livingston KE; Thorsen TS; Kling RC; Granier S; Gmeiner P; Husbands SM; Traynor JR; Weis WI; Steyaert J; Dror RO; Kobilka BK
    Nature; 2015 Aug; 524(7565):315-21. PubMed ID: 26245379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the activation pathway and G
    Mondal D; Kolev V; Warshel A
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26218-26225. PubMed ID: 33020275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the interaction between the atypical agonist c[YpwFG] and MOR.
    Gentilucci L; Squassabia F; De Marco R; Artali R; Cardillo G; Tolomelli A; Spampinato S; Bedini A
    FEBS J; 2008 May; 275(9):2315-37. PubMed ID: 18397320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.
    Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.
    Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Mosier PD; Kellogg GE; Dewey WL; Selley DE; Zhang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1701-15. PubMed ID: 25783191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel hits as highly prospective dual agonists for mu and kappa opioid receptors: an integrated in silico approach.
    Bera I; Marathe MV; Payghan PV; Ghoshal N
    J Biomol Struct Dyn; 2018 Feb; 36(2):279-301. PubMed ID: 28071341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural heterogeneity of the μ-opioid receptor's conformational ensemble in the apo state.
    Sena DM; Cong X; Giorgetti A; Kless A; Carloni P
    Sci Rep; 2017 Apr; 8():45761. PubMed ID: 28368046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.
    Miao Y; McCammon JA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12162-12167. PubMed ID: 27791003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.
    Convertino M; Samoshkin A; Gauthier J; Gold MS; Maixner W; Dokholyan NV; Diatchenko L
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():61-7. PubMed ID: 25485963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists.
    Chen SR; Ke YY; Yeh TK; Lin SY; Ou LC; Chen SC; Chang WT; Chang HF; Wu ZH; Hsieh CC; Law PY; Loh HH; Shih C; Lai YK; Yeh SH; Ueng SH
    Eur J Med Chem; 2017 Jan; 126():202-217. PubMed ID: 27776274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling.
    Podlogar BL; Paterlini MG; Ferguson DM; Leo GC; Demeter DA; Brown FK; Reitz AB
    FEBS Lett; 1998 Nov; 439(1-2):13-20. PubMed ID: 9849868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.